Nephros (NEPH) Equity Average (2016 - 2025)
Historic Equity Average for Nephros (NEPH) over the last 15 years, with Q3 2025 value amounting to $9.8 million.
- Nephros' Equity Average rose 2177.02% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 2177.02%. This contributed to the annual value of $8.5 million for FY2024, which is 171.7% down from last year.
- Per Nephros' latest filing, its Equity Average stood at $9.8 million for Q3 2025, which was up 2177.02% from $9.4 million recorded in Q2 2025.
- In the past 5 years, Nephros' Equity Average ranged from a high of $15.6 million in Q1 2021 and a low of $8.0 million during Q3 2024
- Moreover, its 5-year median value for Equity Average was $9.2 million (2022), whereas its average is $10.7 million.
- Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 4588.51% in 2021, then tumbled by 3862.16% in 2022.
- Nephros' Equity Average (Quarter) stood at $15.0 million in 2021, then tumbled by 38.62% to $9.2 million in 2022, then decreased by 8.03% to $8.5 million in 2023, then decreased by 1.3% to $8.4 million in 2024, then grew by 16.98% to $9.8 million in 2025.
- Its Equity Average stands at $9.8 million for Q3 2025, versus $9.4 million for Q2 2025 and $8.9 million for Q1 2025.